International Tech Times
SEE OTHER BRANDS

Your science and technology news reporter

International Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.

Press releases published on May 1, 2025

Four in 10 Consumers Now Expect Personalized Marketing Experiences

Four in 10 Consumers Now Expect Personalized Marketing Experiences

CHICAGO, May 01, 2025 (GLOBE NEWSWIRE) -- Nearly four in 10 U.S. consumers (39%) expect brands to personalize their online shopping experience with tailored interactions, product recommendations and marketing that align with individual preferences and …

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

BASKING RIDGE, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious …

Canadians reveal top priorities when fleeing disasters: Top 3 things people would grab

Canadians reveal top priorities when fleeing disasters: Top 3 things people would grab

MISSISSAUGA, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- As wildfires, floods, and extreme storms threaten more Canadian communities each year, a new survey from First Onsite Property Restoration reveals what Canadians would grab first when disaster strikes— …

Methanex Announces the Successful Restart of Geismar 3

Methanex Announces the Successful Restart of Geismar 3

VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- Methanex Corporation (TSX:MX) (Nasdaq:MEOH) announced today that its 1.8 million tonne methanol plant, Geismar 3 (G3), in Geismar, Louisiana has successfully restarted and begun producing …

Appili Therapeutics and Colleagues Publish Manuscript on the Prevention and Emergency Response to Tularemia

Appili Therapeutics and Colleagues Publish Manuscript on the Prevention and Emergency Response to Tularemia

HALIFAX, Nova Scotia, May 01, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today …

Parker Reports Fiscal 2025 Third Quarter Results

Parker Reports Fiscal 2025 Third Quarter Results

CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reported results for the quarter ended March 31, 2025, that included the following highlights (compared with the …

Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates

Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, will present its first quarter 2025 financial …

Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

Study ANAVEX3-71-SZ-001 successfully completes enrollment with a total of 71 participants Both Part A (16 participants) and Part B (55 participants) of the placebo-controlled Phase 2 study fully enrolled Top line data expected in the second half of 2025 …

Altimmune to Present at Upcoming EASL International Liver Congress™ 2025

Altimmune to Present at Upcoming EASL International Liver Congress™ 2025

GAITHERSBURG, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced that the …

Prelude Therapeutics to Participate in Citizens Life Sciences Conference

Prelude Therapeutics to Participate in Citizens Life Sciences Conference

WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens Life Sciences Conference taking …

Digi Power X Maintains Strong Cash and Crypto Position with Debt-Free Operations and Reports April 2025 Production Results

Digi Power X Maintains Strong Cash and Crypto Position with Debt-Free Operations and Reports April 2025 Production Results

MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), a vertically integrated power infrastructure company focused on developing cutting-edge data centers for high-performance computing, is …

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

As SVP, Neuroscience, Dr. Bordey will lead Cassava’s ongoing research and development efforts Dr. Bordey to direct the scientific evaluation of simufilam in TSC-related epilepsy, and potentially additional pipeline indications AUSTIN, Texas, May 01, 2025 ( …

WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration

WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration

WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration Geneva, Switzerland, May 1, 2025 –WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading …

HII Reports First Quarter 2025 Results

HII Reports First Quarter 2025 Results

NEWPORT NEWS, Va., May 01, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) today reported results for the first quarter of fiscal 2025. Highlights First quarter revenues were $2.7 billion First quarter net earnings were $149 million or $3.79 diluted earnings per …

Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update

Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update

– Reported positive topline results from the Phase 3 VERITAC-2 trial that support global regulatory filings – – Presented first-in-human data for the Company’s first neuroscience program with ARV-102 showing blood-brain barrier penetration and central and …

Eccogene Appoints Dr. Jai Patel as Chief Medical Officer

Eccogene Appoints Dr. Jai Patel as Chief Medical Officer

BOSTON and SHANGHAI, May 01, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions, today announced the appointment …

BioCryst Appoints Steve Frank to Board of Directors

BioCryst Appoints Steve Frank to Board of Directors

RESEARCH TRIANGLE PARK, N.C., May 01, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed healthcare investment banking leader Steve Frank to its board of directors. Mr. Frank serves as …

Climb Channel Solutions Launches Global Partnership with Accelsius LLC

Climb Channel Solutions Launches Global Partnership with Accelsius LLC

EATONTOWN, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB), is excited to announce its new partnership with …

Lantronix to Report Fiscal 2025 Third Quarter Results on May 8, 2025

Lantronix to Report Fiscal 2025 Third Quarter Results on May 8, 2025

IRVINE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (the “Company”) (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling AI Edge Intelligence, today announced it will release financial results from its fiscal …

Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report first quarter 2025 financial results on May 12, 2025, before the open of the U.S. financial markets. The company does not intend to hold a …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service